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THE ROAD TO IDENTIFYING DISEASE CAUSING GENES: ASSOCIATION TEST, 





Chair: Sebastian Zöllner 
Technological advances now allow investigators to use sequencing data to identify 
genetic risk variants for complex diseases. However, it is still expensive to sequence a 
large sample of individuals. While genotype imputation can augment sequence studies, 
challenges still remain, such as imputation with population or family structures and 
imputation of rare variants. This dissertation aims to tackle these two challenges. 
 
 
The first project considers imputation with family structures, which extended from an 
existing imputation program that assumes unrelated individuals in a sample. I propose a 
strategy for imputing data with family structures and apply it to a family-based 
association study for bipolar disorder. The results suggest the involvement of ion 






The second and third projects provide sampling strategies for next-generation 
sequencing. The goal is to select a subset from a study sample that incorporates maximal 
number of variants when sequenced, or to achieve maximal imputation accuracy when 
impute the sequences of the rest study sample using the sequenced subset or both. In the 
second project, I propose the “most diverse panel” by adapting the concept of the 
phylogenetic diversity. This strategy assumes that the panel with the biggest overall tree 
length in the phylogenetic tree represents the longest evolutionary time, allowing the 
maximal number of mutation events to occur. Sequencing such a panel can thus identify 
the maximal number of variants. In the third project I propose the “most representative 
panel” by considering both the selected and unselected haplotypes. The goal is to identify 
at least one optimal selected reference haplotype for each unselected haplotype. Because 
it is computationally impossible to perform an exhaustive search for a large sample size, I 
develop a hill-climbing algorithm that updates a randomly selected panel a predefined 
number of iterations or until it converges. Using simulated sequence data and real 
sequence data from the 1000 Genomes Project, I compare the two proposed panels to 
randomly selected panels and provide suggestions on which algorithm to use when 




Chapter 1 Introduction 
On the road to identifying disease-causing genes, investigators have successfully 
identified many common variants that are associated with complex diseases through 
GWAS since 2005 (http://www.genome.gov/gwastudies/). However, the fact that those 
identified common variants can only account for a very small proportion of disease 
inheritability motivates investigators to study rare variants for complex diseases. With the 
dramatic cost reduction in next-generation sequencing, investigators start to sequence 
previous samples from GWAS, either by candidate regions or the whole genomes, to 
identify rare risk variants that contribute to the missing disease inheritability. However, 
sequencing a large sample is still expensive. Genotype imputation can augment sequence 
data. In this dissertation, I address how to perform genotype imputation with structured 
data and how we can use genotype imputation in sequencing studies.  
 
Genotype imputation is an important tool in disease gene mapping and has been widely 
used in association studies. It typically uses a densely genotyped panel to predict the 
genotypes in a less densely genotyped study sample (Li et al. 2009). Genotype imputation 
allows direct testing of untyped markers for associations with phenotypes of interest and 
can increase the power for identifying genetic risk variants for complex diseases (Li et al. 
2009; Marchini and Howie 2010). Genotype imputation is often used in meta-analysis to 
combine samples that are genotyped on different platforms (Zeggini et al. 2008; Scott et 




(Li et al. 2010), minimac (Howie et al. 2012), IMPUTE (Marchini et al. 2007), IMPUTE2 
(Howie et al. 2009), and BEAGLE (Browning and Yu 2009). All these programs are 
implemented based on a hidden Markov model, modeling samples as unrelated 
individuals. While each imputation program may provide different imputation quality for 
a specific study sample, reference panel selection affects more in imputation accuracy in 
genotype imputation. Previous studies showed that imputation accuracy was higher when 
the reference panel and the study sample derive from the same or similar populations than 
when they are from substantially different populations (Huang et al. 2009).  
 
In Chapter 2, I conduct a family-based association study for identifying genetic risk 
variants for bipolar disorder in the chromosome 8q24 region. This is a follow-up study to 
narrow down the genetic risk variants that could explain a previously observed linkage 
peak at 8q24 (McInnis et al. 2003; McQueen et al. 2005). McInnis et al. (2003) 
performed a genome-wide scan for bipolar disorder in 65 pedigrees and showed the top 
linkage signal at 8q24 for suggestive evidence of linkage. McQueen et al. (2005) 
performed a meta-analysis that combined 11 studies, including the study by McInnis et 
al. (2003), and reported a genome-wide significant LOD score of 3.4 at 8q24. Using 
family data including the families used in the previous linkage analysis, my collaborators 
genotyped over 3000 SNPs across the 123.1 to 139.1 Mb region at 8q24 for 3,512 
individuals from 737 families (Zandi et al. 2007; Zandi et al. 2008; Zhang et al. 2010). I 
perform a detailed family-based association analysis to evaluate the correlations between 
the common genetic variants in this region to bipolar disorder. In addition, I propose a 




imputation to get the genotypes of all the international HapMap markers for our data (The 
International HapMap Consortium 2005). To extend the imputation of related individuals, 
I perform the imputation in two steps by first calibrating imputation parameters using a 
subset of the study sample with unrelated individual, and then conduct the imputation on 
the entire study sample. In addition, I show that family structure can additionally filter 
out poor imputed markers not detected by other quality control measures. The results 
show suggestive evidence of association between bipolar disorder and loci near three 
genes. Consistent with genes identified by genome-wide association studies for bipolar 
disorder (Ferreira et al. 2008), the results indicate the involvement of ion channelopathy 
in bipolar pathogenesis.  
 
Investigators have performed many genome-wide association studies (GWAS) to test for 
associations of common variants with complex diseases, and have identified thousands of 
SNPs associated with diseases of interest Since 2005 (http://www.genome.gov). 
However, many of these findings in one study are not replicated in other GWAS, possibly 
due to their population differences or the heterogeneity of diseases. The search for 
genetic variants in psychiatric disorders is especially difficult because of their extreme 
heterogeneity in clinical features, diagnosis, and interactions with environmental factors 
(Van Os et al. 2008; Scott et al. 2009; Zhang et al. 2010). So far, only a few large meta-
analyses of schizophrenia and bipolar disorder reported genome-wide significant 





The design of GWAS is to target the common variants (e.g., minor allele frequency > 
0.05) in the genome. Although many GWAS have successfully identified common risk 
variants that are significantly associated with traits of interests, those genetic variants 
combined only contribute to a very small proportion of the observed genetic component 
(Bodmer and Bonilla 2008). On the other hand, less common risk variants, such as 
variants with minor allele frequency less than 0.05, often have large effect sizes for 
disease risk (Cohen et al. 2004; Gibson 2011). With dramatic cost reduction in next-
generation sequencing technology, investigators were able to identify rare genetic risk 
variants through sequencing studies (Shendure and Ji 2008; Li et al. 2011). In principle, 
sequencing can identify most variants in a study sample, especially novel rare variants 
(Cirulli and Goldstein 2010). One caveat, however, is that the rarer of variants, the bigger 
sample sizes are needed to achieve the statistical power for the association testing. 
Sequencing study samples at the GWAS scale is still prohibitively expensive in many 
studies. Thus sampling strategies are often needed for selecting an optimal subset of the 
study sample to sequence. The sequenced subset can then be used as a reference panel to 
impute the rest of the study samples.   
 
In Chapter 3, I introduce an idea of phylogenetic diversity from mathematical 
phylogenetics and comparative genomics and propose the “most diverse reference panel”, 
defined as the subset with maximal “phylogenetic diversity”. The identification of subset 
with maximal diversity has been a common practice in other area of genetics, such as 
biodiversity conservation (Faith 1992; Steel 2005) and biodiversity genome sequencing 




tree length in the phylogenetic tree represents the longest evolutionary time, which allows 
the maximal number of mutation events to occur. Sequencing such a panel can thus 
identify the maximal number of variants.  
 
In Chapter 4, I present another sampling strategy for planning sequencing studies. Instead 
of focusing on maximizing phylogenetic diversity in the selected subset, I aim to 
maximize the similarity between haplotypes in the selected subset (R) and haplotypes in 
the unselected subset (U) by minimizing a distance metric I defined between R and U. To 
locate this optimal realization, an exhaustive search is not computationally feasible for a 
large sample size due to the combinatorial nature of this problem, and there are no 
existing alternative algorithms available. Here I adapt a local search algorithm, the hill-
climbing search, to find a local optimum of R and U. To speed up the search and to avoid 
the algorithm being stuck in a local optimum, I randomly start multiple times and choose 
the one with minimum (R, U) distance as the starting status for the hill-climbing update. 
The goal is to get the global optimum or a local optimum distance that is a reasonable 
approximation of the global optimum (Selman and Gomes 2006). 
 
Using simulated sequence data and real sequence data from the 1000 Genomes Project, I 
compare the two proposed panels to randomly selected panels. The results show that both 
the most diverse panel and the representative panel incorporate more sites that are 
polymorphic and also provide better imputation accuracy when used as reference panels 
than randomly selected panels. The major advantage here is the genotypes for extra 




selected panel. I also compare the performance of the two proposed strategies under 
different settings, such as reference size, imputation length, and maker density in the 
study sample. In the end, I provide some suggestions on which algorithm to use when 
planning sequencing studies with specific study samples based on the observed results 






Chapter 2 A family-based association analysis to finemap linkage peak 
on 8q24 for bipolar disorder 
2.1 Introduction 
Bipolar disorder (BP) is a common, complex psychiatric disease characterized by 
recurrent depression and manias, with an estimated lifetime prevalence of ~1% 
(Merikangas et al. 2007). Family and twin studies have reported a strong familial 
aggregation of BP, suggesting that genetic factors account for 60% to 85% of disease risk 
(Smoller and Finn 2003). While a large number of genetic variants were reported to be 
either linked or associated with BP, few have been replicated (Burmeister et al. 2008; 
Serretti and Mandelli 2008). Only recent large genome wide association studies (GWAS) 
were able to identify the first BP genes. Ferreira et al. (Ferreira et al. 2008) analyzed a 
combined sample of 4,387 BP patients and 6,209 controls and reported genome-wide 
significant associations to BP with SNPs in Ankyrin 3 (ANK3) and in the alpha 1C 
subunit of the L-type voltage-gated calcium channel (CACNA1C), and the same SNPs in 
both ANK3 (Scott et al. 2009) and CACNA1C (Ferreira et al. 2008) were replicated by 
independent studies. However, these two variants account only for a small proportion of 
BP's heritability, most heritable risk remains unexplained. 
 
Some of this heritability may be explained by variants located in regions previously 




human genome map and modern mapping methodologies, over 40 genome-wide linkage 
reports on BP and at least three meta-analysis (Badner and Gershon 2002; McQueen et al. 
2005) were published [for review see (Barnett and Smoller 2009)[. We first reported 
linkage to BP on 8q24 region with an NPL score of 3.25 (Dick et al. 2003; Avramopoulos 
et al. 2004). Cichon et al. (2001) also reported a genome-wide significant two-point LOD 
score (D8S514; LOD = 3.62) at 8q24 in a genome-wide linkage scan of 75 BP families 
(Cichon et al. 2001). These results were included in a meta-analysis of 11 studies by 
McQueen et al. (2005), which reported  a genome-wide significant LOD score of 3.40 in 
a region on chromosome 8q24  under a broad model of BP (BPI and BPII) (McQueen et 
al. 2005). Moreover, Macayran et al. (2006) reported a child with BP carrying a 
duplication of 8q22.1- q24.1 caused by an unbalanced translocation (Macayran et al. 
2006).  
 
To identify genetic variants that account for the linkage signal in this region, we have 
previously performed an association analysis with 249 candidate gene SNPs covering a 
3.4 Mb region in a sample of 583 affected offspring from 258 nuclear families with 
evidence of linkage to BP. We detected suggestive level of associations with SNPs three 
kb upstream of ST3GAL1 (Zandi et al. 2007). We further typed an extended sample of 
3,512 individuals from 737 multiplex families for 1,458 SNPs across a ~16 Mb region on 
8q24. We tested each marker for association with BP, and found suggestive, but not 





However, this SNP panel tagged (r
2
 > 0.8) only ~ 54% of known common 
polymorphisms in the 8q24 region (Zandi et al. 2008). To fill the gaps we designed a 
complementary panel of 1,536 additional SNPs in the same 8q24 region and typed the 
panel on the same sample (Zandi et al. 2008). Here we present the joint analysis of all 
3,072 SNPs. Furthermore, we developed an approach to apply the imputation method 
MACH to family-based data. We imputed 22,725 HapMap SNPs in a ~ 18 Mb regions on 
8q24 flanking the linkage peak reported by McQueen et al. (McQueen et al. 2005). We 
tested all variants for association to bipolar disorder under several genetic models, and 
obtained evidence of suggestive level of association between BP with loci near KCNQ3, 
ADCY8, and ST3GAL1. None of the observed associations are sufficient to account for 
the previous reported linkage signal.  
2.2 Materials and Methods 
2.2.1 Samples 
The study combined the Johns Hopkins sample of 65 families and the NIMH sample of 
672 families; both samples have been described elsewhere [for Hopkins sample (Dick et 
al. 2003); and for NIMH sample (Dick et al. 2003) (Dick et al 2003, McInnis et al. 2003, 
NIHM Human Genetics Initiative Web Site)].  Both samples collected multiplex families 
segregating BP, ascertained for a linkage study of BP. Family members were assessed 
using the Schedule for Affective Disorders - Lifetime Version (SADS-L) (Endicott and 
Spitzer 1978) or the Diagnostic Interview for Genetic Studies (DIGS) (Nurnberger et al. 
1994). Diagnoses of BPI and SABP were based on Research Diagnostic Criteria (RDC) 
in the first sample and DSM-III-R in the second sample (criteria are essentially the same). 




depression.  The final best estimate diagnosis procedure engaged two non-interviewing 
psychiatrists to review all the data for a consensus clinical diagnosis. In the case of 
disagreement a third psychiatrist reviewed discordant diagnoses and adjudicated a final 
diagnosis. 
 
Our sample comprised 3,525 genotyped individuals including 1,383 males and 2,129 
females from 737 families (Zandi et al. 2008). As the initial linkage peak was obtained 
using a broad definition of affection status, we defined individuals diagnosed with BPI, 
schizo-affective disorder, SABP or BPII as affected (n = 1,958), and individuals who 
were determined to be never mentally ill as unaffected (n = 515). The remaining 
individuals were defined as missing disease status (n = 1,052). 
2.2.2 Genotype data 
Genotype data was collected in two phases. We selected 1,536 SNPs in the region from 
123.1 to 139.1 Mb (Build 35) on chromosome 8q24 using FESTA (Gopalakrishnan and 
Qin 2006) for the first phase that was performed at the Center of Inherited Disease 
Research (CIDR) (Zandi et al. 2008). We aimed to tag all the known common variants 
(minor allele frequency, MAF > 0.05) with r
2





in region 131 to 139 Mb. 1,461 SNPs passed quality control and were included in the 
final analysis.  
 
To improve coverage, we selected and typed additional 1,536 SNPs conditional on the 
first marker set  using FESTA (Gopalakrishnan and Qin 2006) We designed this marker 
set to maximize the number of SNPs tagged using the same r
2




Moreover, we retyped 24 SNPs from phase I to estimate genotyping error rates. All 
markers were selected to have an Illumina design cut-off score of 0.6, per manufacturer’s 
instruction, to generate a customized Illumina panel of 1,536 SNPs. These SNPs were 
genotyped using the University of Michigan’s Department of Psychiatry/MBNI 
microarray core facility on a local Illumina Bead Station system, following 
manufacturer’s instruction.  
 
Quality control of the phase II data used PEDSTATS (Wigginton and Abecasis 2005). 
We removed all SNPs that did not satisfy all of the following criteria: successful 
genotyping rate ≥ 90%; number of Non-Mendelian Inheritance (NMI) errors < 6; Hardy-
Weinberg equilibrium (HWE) test using the entire sample with p value ≥ 10
-6
; and MAF 
≥ 5%. After applying these quality control criteria, we retained 1,295 SNPs of the 1,536 
for analysis for a combined dataset of 2,756 SNPs.  
2.2.3 Statistical Analysis 
2.2.3.1 Single marker association analysis 
We performed single marker association tests with program LAMP (Gargus 2006), a 
maximum likelihood method that jointly models linkage and association, to incorporate 
the large family sizes in our dataset (maximum family size, 23). For our main analysis, 
we assumed a multiplicative model with a population prevalence of 1%. In addition, we 
compared to the results obtained under dominant/recessive and a free model without any 





We used the program MACH to impute genotypes for all markers in this 8q24 region 
using the CEU population from HapMap (Build 35) database as references (Macayran et 
al. 2006). MACH implements a hidden Markov model to impute unknown SNP 
genotypes, modeling samples as unrelated individuals. To extend the algorithm to related 
individuals, we performed MACH in two steps by first selecting 200 independent 
individuals to calibrate imputation parameters such as the estimates of imputation error 
rates. Based on these estimates we then imputed genotypes for the entire sample treating 
individuals as independent. In total, we imputed 22,725 SNPs in an 18 Mb region by 
expanding one Mb at each end of our genotyped region.  
 
We evaluated imputation quality using three statistics. First, we estimated imputation 
error rates by masking 2% of the original genotypes before imputation and then 
comparing the true genotypes with their imputed counterparts. Second, we assessed the 
distribution of the quality measure  ̂  calculated by MACH, which is an estimate of the 
squared correlation between imputed genotypes and true genotypes. We excluded 
markers with   ̂       (n = 4,225), which has been shown to remove ~70% of badly 
imputed SNPs (Barnett and Smoller 2009). Moreover, the family structure in our dataset 
allowed us to estimate the imputation quality by counting the number of NMIs for each 
imputed SNPs. We removed imputed SNPs that had > 30 NMIs (n = 1,042). We also 
excluded SNPs that had MAF < 5% (n = 1,905). A total of 15,552 SNPs were included in 





2.3.1 Genotype quality and coverage 
We estimated the genotyping error rate by comparing genotypes of 24 SNPs that were 
typed in both phases for all individuals. The estimated average mismatch rate was 0.26% 
per SNP. Both marker sets together covered 94.1% of the common HapMap SNPs (MAF 
> 0.05) in the 8q24 region, they were either genotyped or covered at r
2
 ≥ 0.50, while 
78.3% of those were either genotyped or covered at r
2
 ≥ 0.80.  
2.3.2 Single marker association analysis 
We carried out the association tests of each SNP with BP under various genetic models 
using LAMP. Here we reported results from a multiplicative model with a disease 
prevalence of 1%. The most significantly associated marker was rs2673582 (p = 4.80×10
-
5
), which located 27 Kb upstream of KCNQ3 (Figure 2.1). Three other SNPs had p-
values < 10
-3
, including rs4871780 (p = 1.20×10
-4
), rs3750889 (p = 5.0×10
-4
) and 
rs1023096 (p = 7.0×10
-4
). Both rs3750889 and rs1023096 are located within ADCY8 
gene and are in high linkage disequilibrium (r
2
 = 0.86) (Table 2.1). Result obtained under 
a dominant/recessive model or a free model was not fundamentally different from these 
results (data not shown). 
2.3.3 Imputation 
To assess the performance of the imputation method MACH on family-based data, we 
randomly masked 2% of genotypes and treated them as missing, then estimated the 
performance by comparing the imputed genotypes to the true genotypes. The estimated 




further assessed the quality of imputed genotypes for each marker using both the number 
of NMIs among imputed SNPs and the estimated  ̂  values generated by MACH. 4,225 
markers failed only the  ̂  -criteria, 1,145 failed only the NMI-criteria and 103 markers 
failed both. While the numbers of NMIs and the imputation  ̂  were negatively correlated 
(coefficient, -0.41), removing imputed SNPs by the number of observed NMIs provided 
an additional filter for identifying poorly imputed markers.  
 
We tested the imputed genotypes of 15,552 SNPs for association with BP using LAMP. 
Our results showed 11 SNPS with p-values <10
-4
 level, with the most significant being 
rs4339604 (p = 9.4×10
-6
, MAF = 0.057, physical position = 128.93 Mb), followed by 
rs7824868 (p = 2.1×10
-5
, MAF = 0.11, physical position = 128.59 Mb) (Figure 2.2). 
Note that the most significant result near 128 Mb is located in a gene desert. 
2.4 Discussion 
We analyzed a sample of 3,512 individuals in 737 families and tested 2,756 genotyped 
SNPs spanning ~16 Mb across the previously identified linkage peak in 8q24 region 
(McQueen et al. 2005). Furthermore, we imputed and tested all common HapMap SNPs 
in this region. Among the genotyped markers, the most significantly associated SNPs are 
located close to 133 Mb near KCNQ3, which is consistent with the linkage peak 
identified by genome-wide linkage analysis. Our result provided further suggestive 
evidence that supported genetic variants in ST3GAL1 or ADCY8 may be associated with 
BP (Table 2.1) (Zandi et al. 2007; Zandi et al. 2008). This association signal is more 
significant than our previous results (Zandi et al. 2008), it is difficult to assess 




tested results in a corrected p = 0.13, for the most significant finding (4.8 x 10
-5
). 
However, Bonferroni correction assumes independent tests and the SNPs in this region 
are highly correlated. Moreover, permutation analysis cannot be applied to assess 
significance because of the family structure in our dataset. Hence it is not clear how to 
assign experiment-wide significance levels. Including imputed SNPs added additional 
signals with suggestive evidence for association, although no SNPs were significant after 
stringent (Bonferroni) correction for multiple testing.    
 
All genes implicated by our analysis have previously been implicated as candidates for 
bipolar and other psychiatric disorders. KCNQ3 has been shown to be expressed highly 
specific to brain and co-expressed with KCNQ2 in most brain regions (Schroeder et al. 
1998). KCNQ2 has been implicated to be associated with BP through phosphatidyl-
inositol phosphate pathway (Carter 2007) and both KCNQ2 and KCNQ3 are key 
components to form a voltage-gated potassium channel that is important in the regulation 
of neuronal excitability (Schroeder et al. 1998). Although no peer-reviewed evidence has 
been forthcoming on KCNQ3 as a susceptibility gene for BP disorder, a recent published 
US patent proposed using a single nucleotide mutation in KCNQ3 gene to assess the 
presence of or predisposition to schizophrenia, BP or a related mental disorder in a 
subject (Chumakov et al. 2006). Furthermore our findings have an intriguing connection 
to replicated GWAS results. ANK3 anchors voltage-gated sodium channels, and both 
ANK3 and subunits of the calcium channel are down-regulated in response to lithium 
treatment in mice (McQuillin et al. 2007). Hence, both the results from ANK3 and that of 




2006), which was also supported by pathway-based analyses on GWAS data in BP 
(Askland K et al. 2009). 
 
The product of ADCY8 catalyzes the formation of cyclic AMP from ATP, where cyclic 
AMP may be involved in BP pathogenesis as a target for lithium and other mood 
stabilizing agents (Perez et al. 2000; Stewart et al. 2001). Malsen et al. showed that 
ADCY8 was differentially expressed in specific brain region as a function of avoidance 
behavior in mice. The author further explored the human homologous 8q24 region using 
a candidate gene approach to test association with BP with genotypes from a GWAS and 
reported nominally significant associations with ADCY8 (p = 0.0055) and KCNQ3 (p = 
0.0029) (De Mooij-van Malsen et al. 2009).The product of ST3GAL1 gene is a type II 
membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to 
galactose-containing substrates. A recent family-based association of candidate genes 
reported evidence of association of ST3GAL1 to BP (empirical p value < 0.005) (Ferreira 
et al. 2008).  
 
As none of the signals we observed can sufficiently explain the linkage signal in 8q24, it 
is likely that additional BP-variants exist in this region. However, as testing 15,552 
additional imputed SNPs did not generate additional interesting signals, our panel of 
2,756 SNPs likely captured most of the common haplotype variation in the 8q24 region. 
Therefore, typing additional common variants in this region would not result in new 
findings. Our results clearly show that the common variants in the 8q24 region do not 




explained by one of two reasons: (1) The linkage peak may be a false positive, and the 
replications of the linkage peak are the result of publication bias. (2) The causal genetic 
variants in this region may be individually rare SNPs or copy number variants, which 
association tests of common SNP markers have low power to detect. To assess the 
contribution of rare variants in 8q24, it will be necessary to sequence a set of candidate 
genes, or the entire 8q24 region in a sample of BP cases. Our results pinpoint to at least 
two potential starting points.   
 
In summary, we identified three biologically feasible signals for association with BP but 
more research is required to understand the contribution of genes in the 8q24 region to 





Table 2.1 Top 10 results of single marker association tests. Results are for genotyped 
markers. I performed the tests under a multiplicative model with a disease prevalence of 
1% using LAMP (Gargus 2006). 
 
Marker  Position(Mb)  MAF Gene  Location  LOD P value  
rs2673582  133.59 0.425 KCNQ3 27Kb upstream 3.59 4.80E-05 
rs4871780  128.36 0.421     3.20 1.20E-04 
rs3750889  132.07 0.406 ADCY8 intron 2.63 5.00E-04 
rs1023096  132.10 0.419 ADCY8 intron 2.49 7.00E-04 
rs6986303  134.55 0.289 ST3GAL1 intron 2.32 1.10E-03 
rs6984550  133.63 0.200 KCNQ3 64Kb upstream 2.27 1.20E-03 
rs10095649  135.23 0.133     1.96 0.0026 
rs4523235  132.31 0.303     1.95 0.0027 
rs10094837  135.27 0.138     1.93 0.0028 
rs17602731  133.59 0.314 KCNQ3 32Kb upstream 1.89 0.0032 






Figure 2.1 LocusZoom plot of association results for genotyped markers.  The top figure 
shows p values (-      ) from association test for each genotyped SNPs versus position 
(Mb) across linkage peak on 8q24 (McQueen et al. 2005). The bottom figure magnifies 
one Mb surrounding the most significant maker rs2673582 (purple diamond). Below each 
plot, a subset of genes in this region is shown. Light gray lines display recombination 
rates as estimated from the HapMap data. The colors of the circles indicate the strength of 












Figure 2.2 LocusZoom plot of association results for all markers.   P values (-      ) for 
association of genotyped and imputed SNPs on 8q24. The horizontal axis shows position 
in Mb. The purple diamond indicates the most significant SNP rs4339604. A subset of 
genes in this region is shown below the main plot. The gray lines indicate recombination 





Chapter 3 Genotype imputation reference panel selection using 
maximal phylogenetic diversity 
3.1 Introduction 
Genotype imputation is an essential component of modern genetic association studies. 
This technique enables direct testing of untyped markers for associations with phenotypes 
of interest, thereby increasing the power to identify causal variants in association studies 
(Li et al. 2009). Imputation is especially useful in meta-analyses that combine data from 
genome-wide association studies (GWAS) performed using different genotyping 
platforms (Zeggini et al. 2008; Scott et al. 2009). Moreover, genotype imputation 
performed using study-specific sequenced samples enables analysis of rare variants 
in large GWAS genotyped datasets (Zawistowski et al. 2010). 
 
Imputation methods typically use a reference panel of densely genotyped haplotypes to 
predict the missing genotypes in a less densely genotyped study sample. The choice of 
the reference panel then influences the imputation accuracy obtained in the study sample. 
It has been observed that in general, imputation accuracy is higher when the reference 
panel and the study sample derive from the same or similar populations than when they 
are from substantially different groups (Huang et al. 2009; Huang et al. 2011). However, 
high-diversity reference panels also contribute to increased imputation accuracy. Huang 
et al. (2009) found that increasing reference panel diversity by incorporating a mixture of 




use of only a single HapMap population. Similarly, in imputing a study sample from a 
British birth cohort, Jostins et al. (2011) found that adding to the reference panel a 
proportion of HapMap samples from other populations (e.g., taking 17% of the reference 
panel from Toscani or 22% from Chinese and Japanese) yielded a higher imputation 
accuracy than using Northern European samples alone.  
 
Most studies performed to date have selected reference panels from external databases 
such as the International HapMap Project (The International HapMap Consortium 2005; 
Frazer et al. 2007) and the 1000 Genomes Project (The 1000 Genomes Project 
Consortium 2010). Dramatic reductions in sequencing cost now enable an alternative 
strategy: to select an internal reference panel for genotype imputation, that is, to 
sequence a subset of the study sample itself and then to use the sequenced subset as a 
reference panel for imputing the rest of the study sample. Using reference sequences 
derived from the study sample can prevent a mismatch in ancestral background between 
the study population and the reference population. It also enables novel variants 
distinctive to the study sample to be imputed. Employing sequences from a candidate 
gene and the 1000 Genomes Project, Fridley et al. (2010) demonstrated the feasibility of 
imputing genetic variants based on a sequenced proportion of a study sample, and they 
suggested sequencing “the largest and most diverse” subset. In a theoretical study, Jewett 
et al. (2012) found that including sequenced haplotypes from the study population in the 
reference panel improved imputation accuracy, even if the external panel was taken from 
a closely related population. Here, we develop criteria for the selection of an internal 




choosing an internal reference panel from the study sample, with the aim of 1) 
maximizing the number of polymorphic sites in the imputed dataset and 2) achieving the 
maximal imputation accuracy. 
 
The identification of maximally diverse subsets of a larger set of individuals has been a 
goal in other areas of genetics, such as in choosing diverse sets of plant accessions for 
inclusion in core collections targeted for agronomic development or experimental use 
(Brown 1989; McKhann et al. 2004; Reeves et al. 2012) and in choosing diverse species 
sets for biodiversity conservation (Faith 1992; Steel 2005) and genome sequencing (Pardi 
and Goldman 2005). In selecting a set of imputation templates, we borrow the concept of 
“phylogenetic diversity” which, for a given subset of a larger set of taxa, measures the 
fraction of the total branch length of an evolutionary tree of the larger set that is included 
in the restriction of the tree to the taxon subset (Faith 1992; Nee and May 1997; Steel 
2005). Conditional on a tree of n taxa, Pardi and Goldman (2005) and Steel (2005) 
proved that among all possible subsets of size m ≤ n taxa from the larger set, the globally 
maximal phylogenetic diversity can be obtained by a greedy algorithm. This greedy 
algorithm provides a computationally efficient solution to a form of combinatorial 
optimization problem that can usually only be solved via exhaustive analysis of all 
possible subsets. Further, if it becomes possible for investigators to increase the number 
of sequenced samples, for example, by an increase in budget, then the greedy algorithm 






We propose the use of the most diverse reference panel for genotype imputation, adapting 
the greedy algorithm for maximizing phylogenetic diversity in our selection of an internal 
reference panel. We assume phased diploid individual genotypes are available, as phasing 
is not our focus. We approximate the ancestral relationships of haplotypes by 
constructing a neighbor-joining phylogenetic tree (Saitou and Nei 1987) using the 
pairwise Hamming distance matrix between the haplotypes in a study sample (Figure 
3.1). We next apply the greedy algorithm of Pardi and Goldman (2005) and Steel (2005) 
to identify the subset at a given size with the maximal “phylogenetic diversity” 
conditional on the tree. Similar to a method of template selection by Pasaniuc et al. 
(2010), our approach is tree-based, but we aim to choose a maximally diverse subset, 
whereas Pasaniuc et al. (2010) select a subset from an external dataset based on similarity 
between haplotypes in the external dataset and each individual haplotype in the study 
sample. The haplotypes chosen by our method are spread across the tree and tend to have 
long external branch lengths (Figure 3.1, bold lines), as our method prioritizes individual 
sequences that are more differentiated. We expect that in comparison with a random 
subset, the subset that is most phylogenetically diverse at the genotyped markers also 
carries a larger number of polymorphic sites that can be identified by sequencing, and 
that are then available for imputation into the remaining sample when this sequenced 
subset is used as a reference panel. Thus, this strategy enables more variants to be 
imputed in the study sample than with the use of a randomly selected reference panel.  
 
Kang and Marjoram (2012) recently proposed a similar tree-based sample-selection 




unweighted pair group method with arithmetic mean (UPGMA) (Sokal and Michener 
1958), which is designed for ultrametric data in which each haplotype has the same 
distance to the root of the constructed tree. The subtree identified by the method of Kang 
and Marjoram (2012) also requires the ultrametric assumption in order to have a maximal 
tree length. In contrast, the neighbor-joining method we use does not require data to be 
ultrametric.  
 
To evaluate the performance of our "most diverse reference" panel in genotype 
imputation, we simulate sequences and create study samples similar to those observed in 
GWAS by masking the genotypes for a number of single nucleotide polymorphisms 
(SNPs). We then impute the masked genotypes in the study sample by using either the 
most diverse reference panel or by using randomly selected reference panels. We also 
apply the “most diverse” method to sequences of European ancestry from the 1000 
Genomes Project. The results from both the simulated sequences and the 1000 Genomes 
sequences show that the most diverse reference panel consistently provides higher 
imputation accuracy, independent of imputation lengths, reference panel sizes, and 
marker densities in the study sample. We thus provide a cost-effective strategy for 
designing sequencing studies for samples with existing genome-wide genotype data. As 
of 2013, thousands of GWAS have been performed, with over one million genotyped 
individuals (http://www.genome.gov/gwastudies/). Effective use of the genotype data 
will make it possible to carry out large-scale sequencing studies on these individuals in 




3.2 Materials and methods 
3.2.1 Phylogenetic diversity 
We use notation similar to that of Steel (2005). Assume a study sample T of n haploid 
individuals, each containing q polymorphic sites that are genotyped for k < q variable 
sites (referred to as markers) in a region of interest. We consider haploid data (phased 
diploid individuals for humans), as we do not focus on phasing. Based on the genotypes 
at those k markers, we aim to identify a subset       of size m ≤ n to be sequenced. 
Sequencing reveals r ≤ q - k additional variable sites in the m individuals. S is then used 
as a reference panel to impute the genotypes of these r sites in the remaining n - m 
individuals in the study sample T.  
 
To identify the optimal selection of S, let XT be an unrooted tree constructed using all 
haplotypes in T on the basis of the k markers. Let λT be the sum of the branch lengths for 
all edges of XT. We denote by XS the induced tree obtained by restricting XT to only the 
haplotypes in S and by λS the sum of the branch lengths of XS. For m ≥ 2, we define the 
size-m subset of T with maximal phylogenetic diversity as pdm: 
 
          {           | |   }. 
 
3.2.2 Identifying the subset with maximal diversity 
To find pdm, we first generate an unrooted tree from the study sample T. Based on the 




haplotypes and construct a pairwise distance matrix for T. Based on this distance matrix, 
we construct a tree using the neighbor-joining method, which recursively agglomerates 
pairs of nodes until all nodes have been incorporated into the tree (Saitou and Nei 1987).  
On this tree, we apply a greedy algorithm to identify the subset S with size m that has the 
maximal phylogenetic diversity. Briefly, we first select the pair of haplotypes with the 
greatest distance on the tree and add the pair to S. We then sequentially incorporate as the 
next haplotype in S the haplotype that adds the maximal length to the chosen tree at that 
step, repeating the process until S reaches size m. Pardi and Goldman (2005) and Steel 
(2005) proved that conditional on the tree, the subset chosen according to this greedy 
algorithm has the maximal phylogenetic diversity. 
3.2.3 Simulations 
We analyze simulated datasets to evaluate the performance of the “most diverse reference 
panel” in genotype imputation. We independently generate 50 datasets of 2000 
haplotypes each with the program ms, a coalescent-based sequence sampling program, 
under the neutral Wright-Fisher model (Hudson 2002). We assume a basic population-
genetic model with constant effective population size Ne = 10,000, a mutation rate µ = 
1.0
-8
 per site per generation, and a recombination rate ρ = 1.0
-8
 per site per generation. 
We remove singletons from the simulated sequences to create the "true" imputable 
sequence data. All simulated sites are assumed to have at most two alleles. Emulating the 
density of current genotype arrays, we select the marker panel of the study sample (the 
"genotype data") by randomly choosing 300 markers per Mb that have MAF > 0.1 in the 
sequence data. We mask the genotypes for the remaining sites, which become the set of 




100 kb while keeping the genotypes for the marker panel in both 450-kb flanking regions 
to improve imputation accuracy and to avoid edge effects (Li et al. 2010). Based on these 
simulated marker genotype datasets, we apply our algorithm on the marker panel to 
obtain the most diverse reference panels of 200 haplotypes. To evaluate the performance 
of the most diverse reference panel, for each of the 50 simulated datasets, we generate 
1000 random reference panels, by sampling without replacement 200 haplotypes each 
from the sequence data for comparison. We ignore the pairing status of two haplotypes in 
a diploid individual when selecting the most diverse panel. In practice we can not only 
sequence one chromosome in a diploid individual. To incorporate this more realistic case, 
we consider the pairing status in diploid case and form the “diverse diploid panel”. If we 
plan to sequence 100 diploid individuals out of 1000 diploid individuals, we form the 
diverse diploid panel by continuing to incorporate diploid individuals who carry one or 
two haplotypes into the panel from the top diversity list until we reach 100 diploid 
individuals. In each reference panel, we unmask all imputable sites and use the resulting 
sequences as references for genotype imputations. For each dataset, we perform one 
imputation with the most diverse reference panel, one imputation with the diverse diploid 
reference panel, and one imputation with each of the 1000 randomly selected reference 
panels. 
 
To evaluate the impact of our parameter choices, we modify this basic design by 
changing the length of the imputation target, the reference panel size, and the number of 
genotyped SNPs in a study sample while maintaining the other parameters fixed as 




Mb, each time adding 450 kb flanking regions. We select reference panel sizes of 100, 
200, 300, 400, and 500 haplotypes among a total of 2000 haplotypes. We also vary the 
number of genotyped markers from 300 to 1000 in a 1 Mb region in a study sample. For 
each scenario, we simulate 50 datasets of 2000 haplotypes each. For each dataset, we 
perform one imputation with the most diverse reference panel and 50 imputations with 
randomly selected reference panels.  
 
Based on previous comparisons among imputation methods (Hao et al. 2009; Nothnagel 
et al. 2009; Pei et al. 2010), we employ minimac (Howie et al. 2012) as one of the best-
performing methods. This method is an extension of MaCH (Li et al. 2010) for phased 
diploid data. To assess imputation accuracy on heterozygous genotypes, we then create 
n/2 diploid individuals by randomly combining pairs of haplotypes from the entire study 
sample. After imputation, we evaluate the predicted imputation accuracy by examining 
for each selected reference panel the mean of the estimated correlation coefficient  ̂  
across all markers. To evaluate the imputation accuracy of the r imputed sites for the n/2 
diploid individuals in the imputed datasets, we compute two measures for the discordance 
rate between the imputed genotypes  ̂   and the simulated genotypes     at variant site   
in target individual  . We let  ̂   and     equal to 0, 1 and 2, based on their numbers of 
copies of one specific allele. First we calculate discordance rate  across all sites: 
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sites examined (Huang et al. 2009), we also calculate imputation errors across all 
heterozygous genotypes (     ): 
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3.2.4 The 1000 Genomes Project data 
We apply our method to sequence data from the 1000 Genomes Project. We consider the 
phased data of 381 diploid individuals (762 haplotypes) with EUR (European) ancestry, 
including 87 CEU (Utah residents with Northern and Western European ancestry), 93 
FIN (Finnish from Finland), 89 GBR (British from England and Scotland), 14 IBS 
(Iberian populations in Spain), and 98 TSI (Toscani in Italy) 
(http://www.sph.umich.edu/csg/abecasis/MACH/download/1000G-PhaseI-Interim.html, 
the 1000G Interim Phase I Haplotypes 11/23/2010 release). We remove singletons from 
the sample, selecting eight 100-kb regions that are approximately evenly distributed 
across chromosome 20. We create study samples using a similar procedure as the 
simulation above: for each region, we add a 450-kb flanking region on each side, 
randomly choose ~300 genotyped SNPs per Mb among markers with MAF ≥ 0.1, and 
mask the genotypes of all other sites. In each region, we select the most diverse 160 
haplotypes from the set of 762 total haplotypes as the diverse reference panel. For 






We next consider the entire chromosome 20 and create a study sample using the same 
procedure as in the 100 kb regions. We select the most diverse reference panel using our 
method and 50 reference panels randomly without replacement. Using the selected 
reference panels, we impute all the masked genotypes and compute the discordance rate 
for each imputation. 
3.3 Results 
3.3.1 Number of imputed sites 
Polymorphic sites in reference panels: Only sites that are polymorphic in the reference 
panel can be imputed into the remaining study sample. Hence, we first evaluate the 
number of polymorphic sites in the reference panels selected. For each of the 50 
simulated datasets, we choose one random reference panel and compare it to the most 
diverse reference panel. We find that for a total of 12,957 masked sites that are 
polymorphic in the study samples across the 50 datasets, 9,642 of sites (74.41%) are 
polymorphic in both types of reference panels. Among the remaining sites, 1,492 sites 
(11.52%) are polymorphic only in the most diverse reference panels, whereas 760 sites 
(5.87%) are polymorphic only in the randomly selected reference panels. Thus, on 
average, 5.65% more sites are polymorphic in the most diverse reference panels than in 
the randomly selected reference panels. 
 
Polymorphic sites in imputed datasets: To ensure that the higher number of polymorphic 
sites in the most diverse reference panels also leads to a higher number of imputed 
polymorphic variants, we count the number of imputed sites that are polymorphic in 




strategies: (1) sampled at random, (2) selecting the 200 most diverse haplotypes and (3) 
selecting the diverse considering the haplotype pairing status (diverse diploid reference 
panel). As it is not currently practical to sequence only one chromosome in a diploid 
organism, strategy (3) represents a scenario in which the individuals that carry the most 
diverse haplotypes are identified and both of their chromosomes are sequenced. Across 
the 50 datasets, the mean number of haplotypes that one diverse diploid panel of 200 
incorporates from the top diversity list is 106, ranging from 102 to 112. Assuming Hardy-
Weinberg equilibrium, this second chromosome is sampled randomly from the 
population. 
 
From the total of 12,957 imputed sites across the 50 datasets, 10,952 are polymorphic in 
datasets imputed with the most diverse reference panels (84.53%), 10,574 are 
polymorphic for the diverse diploid reference panels (81.61%), and 10,151 are 
polymorphic for randomly selected reference panels (78.34%). Figure 3.2 shows 
percentages of polymorphic sites in datasets imputed with the three reference types across 
the 50 datasets. In each of the 50 datasets, imputation with the most diverse reference 
panel captures more polymorphic sites than imputation with the random reference panel. 
The improvement by using the most diverse panel is greater when the randomly selected 
panel captures only a low percentage of polymorphic sites (e.g., replicates 46 to 50). 
Imputations with the diverse diploid panels result in higher percentages of polymorphic 
sites than the random panels in 42 of the 50 datasets (84%) and in a higher percentage of 
polymorphic sites than the most diverse panel in 4 of the 50 datasets (8%). Only in four 




diploid reference panel (replicate 1, 2, 3, and 6) and in all these cases, the random panel 
captures a high (> 83%) percentage of polymorphic sites.  
3.3.2 Imputation accuracy 
As a measurement of imputation accuracy, we evaluate the discordance rate between the 
simulated genotypes and the imputed genotypes for the 50 simulated datasets. For each 
dataset, we compare the accuracy of the imputation using the most diverse reference 
panel to the empirical distribution of imputation accuracies from 1,000 random reference 
panels.  
 
Estimated imputation quality: A predictor for the accuracy of an imputed site generated 
by minimac is the  ̂ , a quantity calculated by comparing the variance of observed 
genotype scores with the variance of expected genotype scores to estimate the squared 
correlation at a marker between the true allele counts and the estimated allele counts (Li 
et al. 2010). To compare this predicted imputation accuracy between the different choices 
of reference panels we compute the average  ̂  across the 12,957 total imputed sites 
across the 50 datasets. For imputations with the most diverse reference panels and the 
diverse diploid reference panels, we generate one value of  ̂  for each site; to evaluate 
imputations with the 1000 randomly selected reference panels for each dataset, we 
compute the mean  ̂  for each site across 1000 imputations, and we then calculate the 
average across all imputed sites. Sites imputed with the most diverse reference panels 
have the highest mean  ̂2 (0.784), followed by sites imputed with the diverse diploid 
reference panels (0.758). Sites imputed with randomly selected reference panels have the 




imputed sites (Li et al. 2009), we also compare the number of sites that pass this 
imputation quality threshold. Across the 50 datasets, we observe that a higher percentage 
of sites imputed with the most diverse reference panels pass the threshold (83.17%) 
compared to sites imputed with the diverse diploid reference panels (80.53%) and sites 
imputed with the randomly selected panels (77.48%). For a higher  ̂  threshold of 0.8 
applied by typical association studies, 76.63% of sites pass the threshold for imputations 
with the most diverse reference panels, 74.76% for the diverse diploid reference panels, 
and 59.65% for the randomly selected reference panels. 
 
Discordance rates: For each simulated dataset, we separately calculate discordance rates 
for all sites imputed with the most diverse reference panel, sites imputed with the diverse 
diploid reference panel, and the mean values for sites imputed with random reference 
panels taken across all 1000 random panels. Using the most diverse reference panel 
results in the lowest mean discordance rate across the 50 replicates (0.0019), followed by 
imputation with the diverse diploid reference panel (0.0022). Both quantities are lower 
than the mean discordance rates of imputation with the random reference panels (0.0031) 
(Figure 3.3). Ranking the discordance rate of selected reference panels together with the 
discordance rates of 1000 random panels from the lowest to the highest value, the most 
diverse reference panel is a clear outlier for 24 of the 50 datasets (48%), having a lower 
discordance rate than imputations with all 1000 randomly selected reference panels (rank 
1). Across all 50 datasets, the mean rank of the most diverse reference panel is 13.5, 
ranging from 1 to 135 among 1001 panels. Across the same 50 datasets, the mean rank of 





To generate a more meaningful discordance measure for low-frequency variants, we also 
compare the imputed genotypes and the simulated true genotypes across sites for which 
the true genotypes are heterozygotes. While the heterozygote discordance rate is higher 
than the overall discordance rate, the mean heterozygote discordance across the 50 
replicates is again the lowest for sites imputed with the most diverse reference panels 
(0.0097), followed by the diverse diploid reference panels (0.0121) and the random 
reference panels (0.0165). Comparing across frequency bins, we observe that for all 
reference selection strategies, the heterozygote discordance rate decreases with increasing 
allele frequency. The mean heterozygote discordance rate across the 50 replicates for 
low-frequency variant sites (0 < MAF < 0.1) is considerably higher than the overall mean 
discordance rate for all heterozygote sites across the 50 replicates (0.0258 for the most 
diverse reference panels, 0.0329 for the diverse diploid reference panels, and 0.0415 for 
the random reference panels). In all frequency bins, considering heterozygote discordance 
rates, imputations with the most diverse reference panels generate the lowest discordance 
rates and imputations with the randomly selected reference panels generate the highest 
discordance rates, while imputations with the diverse diploid reference panels generate 
intermediate discordance rates (Figure 3.3). Combining the heterozygote discordance 
rate of the most diverse reference panel with the heterozygote discordance rates of 1000 
random panels for each of the 50 simulated datasets and ranking from the lowest to the 
highest heterozygote discordance rate, the mean rank of the most diverse panel across all 
50 datasets is 17.5 when comparing all heterozygote sites, 27.3 for sites with 0 < MAF < 




1001 panels ranked. When comparing the diverse diploid reference panel to random 
panels, the mean rank across all 50 datasets is 147.9 for all heterozygote sites, 188 for 
sites with 0 < MAF < 0.1, 163.9 for sites with 0.1 ≤ MAF < 0.2, and 145.9 for sites with 
0.2 ≤ MAF ≤ 0.5. 
3.3.3 Imputation accuracy under different simulation settings 
To assess the robustness of our results, we evaluate the performance of the most diverse 
reference panel under different simulation settings, considering different target sequence 
lengths, different reference panel sizes, and different marker densities in the study 
sample. We first investigate whether the lengths of the target regions affect the 
performance of the most diverse reference panels in imputations. We impute regions with 
lengths of 100 kb, 500 kb, 1 Mb and 2 Mb, using both the most diverse reference panel 
and 50 random reference panels, each of which is compared to the true underlying 
genotypes; the average of the 50 discordance rates is then compared with the discordance 
rate for the most diverse reference panel. As shown in Figure 3.4a, across the four 
different lengths, we observe little effect of the imputation length on the discordance rate. 
The mean discordance rate across the 50 replicates for each group ranges from 0.0028 (2 
Mb) to 0.0037 (500 kb) for the most diverse reference panel and from 0.0052 (2 Mb ) to 
0.0058 (100 kb) for the random reference panels. For all sequence lengths considered, the 
most diverse reference panels provide lower discordance rates than the randomly selected 
reference panels.  
 
Second, we evaluate how the reference panel sizes affect the performance of the most 




of size 100, 200, 300, 400, and 500 haplotypes. For both reference panels, the mean 
discordance rate across the 50 replicates decreases with larger reference panel sizes, from 
0.008 to 0.0006 for the most diverse panel and from 0.009 to 0.0015 for the random 
reference panels. Especially for a reference panel of size 100 individuals, the discordance 
rate is considerably higher than for larger panel sizes. Across all reference panel sizes, 
imputations with the most diverse reference panels consistently provide lower 
discordance rates than do imputations with the randomly selected reference panels 
(Figure 3.4b).  
 
Third, we examine how the number of markers genotyped initially in the study sample 
affects the performance of the most diverse reference panel by varying the density of 
markers in the study sample, considering 200, 300, 400, 500, 600, and 1000 markers per 
1 Mb region. For both types of reference panels, the mean discordance rate across the 50 
replicates decreases with a higher density of markers in the study samples, from 0.0055 to 
0.0015 for the most diverse panel and from 0.0072 to 0.0023 for the random reference 
panels. Across all marker densities in the study sample, the most diverse reference panels 
consistently provide lower discordance rates than the randomly selected reference panels 
(Figure 3.4c).  We also observe that the improvement in discordance rates for the most 
diverse reference panel over the randomly selected panels slightly decreases with more 





3.3.4 Imputation accuracy on data from the 1000 Genomes Project 
We apply our method to real sequence data of 381 phased individuals with EUR ancestry 
from the 1000 Genomes Project. Considering eight 100-kb regions across chromosome 
20, we impute 3,215 sites after removing singletons. Sites imputed with the most diverse 
reference panels have a mean  ̂2 of 0.749 across sites; sites imputed with the 1000 
randomly selected reference panels have a mean  ̂2 of 0.741. Slightly more sites pass the 
imputation quality threshold of  ̂2 ≥ 0.3 for the most diverse reference panels (85.75%) 
than for the randomly selected reference panels (84.23%). When applying a higher 
imputation threshold of  ̂2 ≥ 0.8, a similar percentage of sites pass the threshold for the 
most diverse reference panels (62.74%) and the randomly selected reference panels 
(62.89%). 
 
Considering all imputed sites for the eight 100-kb regions, the most diverse reference 
panels result in a lower mean discordance rate across the eight regions (0.0067) than the 
randomly selected reference panels (0.0077). When comparing imputed sites that are 
heterozygotes in real sequenced datasets, sites imputed with the most diverse reference 
panels have a lower mean discordance rate across the eight regions (0.0228) than sites 
imputed with the randomly selected reference panels (0.0262). The lower discordance 
rates from the most diverse reference panels are observed across all frequency bins for 
heterozygote sites:  For sites with 0 < MAF < 0.1, the mean discordance rate across the 
eight regions is 0.074 using the most diverse reference panels versus 0.0895 using 
random reference panels, for sites with 0.1 ≤ MAF < 0.2, the mean discordance rate 




mean discordance rate across the eight regions is 0.0080 versus 0.0099 (Figure 3.5). 
However, we also notice that the performance of the most diverse reference panel varies 
widely among the eight regions. When ranking the discordance rate of the imputation by 
the most diverse reference panel with the discordance rates of the 1000 imputations by 
randomly selected reference panels from the lowest to the highest value for each of the 
eight regions, the most diverse reference panel has an average rank of 116.1 across the 
eight regions, ranging from
 
3 to 496 out of 1001 panels ranked. For heterozygote sites, 
the most diverse reference panel has an average rank of 156.7, ranging from 1 to 508; for 
heterozygotes in different MAF bins, the most diverse reference panel has an average 
rank of 242.7 for sites with 0 < MAF < 0.1, an average rank of 311.0 for sites with 0.1 ≤ 
MAF < 0.2, and an average rank of 129.4 for sites with 0.2 ≤ MAF ≤ 0.5 out of 1001 
panels ranked.  
 
For the whole chromosome 20 data, the sequence dataset contains 259,618 sites after 
removing singletons. We select 18,000 sites with MAF ≥ 0.1 as “genotyped” markers and 
mask the genotypes for the remaining 241,618 sites to create a study sample. Based on 
the genotyped markers, we select the most diverse reference panel to impute the 
genotypes of the masked sites. For comparison, we sample 50 reference panels at 
random. We first compare the number of masked sites that are polymorphic in the 
selected reference panels. In the most diverse reference panel, 211,480 masked sites are 
polymorphic (87.53%), compared to an average of 210,137 across the 50 random 
reference panels (86.97%). After imputation, we observe that the imputation with the 




sites have mean  ̂2 ≥ 0.3 with a randomly selected reference panel (83.03%). For the 
higher imputation quality threshold of  ̂2 ≥ 0.8, 142,996 sites pass the threshold for the 
imputation with the most diverse reference panel (59.18%), whereas averaging 142,281 
sites across imputations with the 50 randomly selected reference panels pass the threshold 
(58.89%). Moreover, sites are imputed slightly more accurately with the most diverse 
reference panel than with random reference panels (Table 3.1). The discordance rate of 
the most diverse panel is lower than all except 2 of the 50 random panels (rank 3). To 
evaluate the imputation accuracy in different frequency bins, we again consider 
discordance rates of heterozygote genotypes. When ranking the discordance rate of the 
imputation by the most diverse reference panel with the discordance rates of the 50 
imputations by randomly selected reference panels from the lowest to the highest value, 
we observe that the most diverse reference panel has a lower discordance rate than all 50 
random panels (rank 1). Examining separate frequency bins, the most diverse reference 
panel has rank 4 for sites with 0 < MAF < 0.1, rank 3 for sites with 0.1 ≤ MAF < 0.2, and 
rank 14 for sites with 0.2 ≤ MAF ≤ 0.5. Averaging across sites, the numerical 
improvement in imputation accuracy by using the most diverse panel is modest, reducing 
imputation errors by 1% across all sites and by 2.3% at less common variants with 0 < 
MAF < 0.1. 
3.4 Discussion 
The cost reduction in modern sequencing technology enables investigators to generate a 
reference panel for genotype imputation by sequencing a subset of the study sample. We 
have proposed a sampling strategy for such an internal reference panel by adapting an 




consistently outperforms randomly selected reference panels, in that it provides higher 
imputation accuracy and recovers more polymorphic sites from the sample. This 
improved performance holds across different imputation lengths, different reference 
panel sizes, and different marker densities in the study sample. Upon analyzing real 
sequence data with European ancestry from the 1000 Genomes Project, the most diverse 
reference panel provides higher imputation accuracy than do randomly selected reference 
panels. We observe this improved performance when imputing eight 100-kb regions on 
chromosome 20 and when imputing the entire chromosome 20, indicating that our 
method can be used to select reference individuals for imputing smaller target regions as 
well as for imputing entire genomes. Our method may be particularly advantageous for 
imputing less common variants, as we found in our simulations that the most diverse 
reference panels have more polymorphic sites than do randomly selected reference 
panels. Moreover, the accuracy gain from using the most diverse reference panel instead 
of randomly selected reference panels is greater for less common variants (e.g., 0 < MAF 
< 0.2) than for more common variants (e.g., MAF ≥ 0.2) (Table 3.1). 
 
Our method is fundamentally different to Pasaniuc (2010). Although both selections are 
based on the genotypes of makers that exist in the study sample and reference sequences, 
we adapt phylogenetic diversity in our method whereas Pasaniuc and colleague’s method 
identifies one different reference panel for each short window (e.g., 15 kb) of the target 
region for each study individual based on coalescent theory. In addition, their method 
requires having a pool of sequences to select from. This is not the case for our purpose as 




Kang and Marjoram (2012) very recently considered sample selection for next-generation 
sequencing using a similar approach based on maximizing the subtree length. Compared 
to our NJ method, Kang and Marjoram used the UPGMA tree. In general, the NJ method 
is more accurate in computing branch lengths as it considers all taxa on the tree when 
estimating branch lengths whereas UPGMA only select the closest neighbors and 
compute the arithmetic mean. In addition, Bryant (2005) proved the NJ is statistically 
consistent given the distance data whereas UPGMA does not always satisfy the 
consistency criteria. Finally, UPGMA requires the ultrametric condition, the final tree is a 
clock-like tree and each individual on the tree has the same distance to the root. As a 
result, we expect the method based on UPGMA to have more ties that evolve sample 
uniformly at random in selecting a subset with maximal tree length than our method as 
our NJ tree does not require the ultrametric assumption. Although they have used a 
different tree-building algorithm, they examined a similar greedy method, motivated by 
coalescent theory instead of from the standpoint of phylogenetic diversity. In simulations 
that examined different marker densities, target imputation region lengths, and reference 
panel sizes, they found that their algorithm performed well, and we similarly find that our 
related method performs well under these scenarios. In addition, the work of Pardi and 
Goldman (2005) and Steel (2005) provides further theoretical justification for the basis of 
our algorithm, as well as for the method of Kang and Marjoram. Taken together, our 
study and that of Kang and Marjoram demonstrate the value of sensible use of 
genealogical relationships among samples to improve the experimental design for 




incorporate other selection criteria by starting with an initial selection of haplotypes and 
then applying the greedy algorithm as an extension. 
 
We expect that the most diverse reference panel algorithm can work effectively either on 
a limited region of the genome or on whole chromosomes, provided the phylogenetic tree 
based on existing data reasonably captures the ancestral relatedness of the haplotypes in 
the study sample. This is only possible if this ancestral relatedness can be described well 
as a tree, a condition that depends on the population-genetic history of the sample and the 
size of the region of interest. When focusing on a single genomic region, relevant parts of 
its ancestral process can be approximated as a tree due to limited recombination events. 
This single tree can be estimated by a subset of genotyped markers, and thus, our method 
can provide useful information for reference panel selection. On the other hand, many 
uncorrelated trees can be formed to represent the ancestral processes of a large region 
such as the entire genome. Hence, an approximation with a single tree might not capture 
many features of the data. In such a scenario, it is less likely that our method will produce 
a better reference panel than a random sample. In a structured population, the underlying 
population structure generates a correlation of ancestries across the entire genome. The 
resulting clades can be approximated by the tree-building algorithm, and this tree can 
help in selecting a more diverse reference panel. It is encouraging that in a sample of five 
European subpopulations, the population structure was sufficient for the most diverse 
reference panel selected based on the entire chromosome 20 to outperform the randomly 
selected reference panels. Hence, relatively subtle population structure, such as that found 




the underlying ancestral processes that can be captured by the tree-building algorithm and 
can result in improved reference panel selection. For subpopulations with different 
sample sizes, we expect the diverse algorithm only oversample from subpopulations with 
many individuals that have dramatic longer external branch lengths that individuals from 
other subpopulations on the constructed tree, or undersample in the case of dramatic short 
external branch lengths. Otherwise, we expect our algorithm will pick the number of 
individuals that are proportional to the size of each subpopulation.  
 
Our method is based on local phylogenetic tree. The topology of the local phylogenetic 
tree may change with increasing size of a genome region because of recombination 
events. As the performance of our method is based on how well the local phylogenetic 
tree approximates the ancestral relatedness of the study individuals, we expect the gain in 
imputation accuracy using our method will decrease with increasing length of an 
imputation region. As expected, the average improvement in imputation accuracy when 
imputing 100-kb regions is considerably higher than the average improvement across the 
entire chromosome, reflecting that the ancestry of a 100-kb region is more tree-like than 
the ancestry of an entire chromosome. However, the average improvement in imputation 
accuracy when imputing 100-kb regions is considerably higher than the average 
improvement across the entire chromosome, reflecting that the ancestry of a 100-kb 
region is more tree-like than the ancestry of an entire chromosome.  
 
The method of reference panel selection described here can be adapted to address specific 




panel selection. For example, we have not specifically incorporated phenotype 
information when selecting reference haplotypes, so the selected reference panel is not 
guaranteed to include the individuals with traits of interest. To sequence certain 
individuals because of their phenotypes or other criteria unrelated to their phylogenetic 
placement, we can apply the selection algorithm conditional on including these 
individuals in the reference panel. The greedy algorithm still guarantees that the 
subsequent extension has optimal phylogenetic diversity, as proved in Pardi and Goldman 
(2005). Similarly, our method can be easily extended to form a reference panel by 
incorporating sequences partly from the study sample and partly from an external 
database such as the HapMap Project or the 1000 Genomes Project. For example, we can 
treat sequences from the HapMap Project as an initial set and apply the greedy algorithm 
to the study sample as an extension in a similar manner as in analyses treating other 
inclusion criteria. 
 
Our method should be applicable to imputation in other species of a genome region in 
other species as long as the constructed tree can reasonably represent the ancestral 
relatedness among the study individuals. Wang et al. (2012) proposed to use local 
phylogenetic tree to provide confidence information in imputing sequences in inbred 
mice. The confidence is high for imputing study strains that share one or more genome 
intervals with reference sequences, whereas the confidence is low for strains that do not 
share genome intervals with reference sequences. The authors also proposed that 
sequencing these strains with low confidence imputation quality could provide maximal 




Wang et al (2012) may work well as an extension to our study to combine existing 
sequence data in imputation. For example, to get the full sequences of a genome region 
for a study sample, we can form a reference panel from the 1000 Genomes Project that 
share one or more haplotypes with our study sample and impute the sequences of the 
these study individuals with high confidence, and apply the our method to the rest of 
study individuals or sequencing all the rest of study individuals if budget allows. 
 
In summary, we have demonstrated that an innovative method of choosing an internal 
reference panel — the most diverse reference panel — can be a cost-effective approach 
for planning sequencing studies with existing genotype array data. The method can 
readily incorporate a variety of selection criteria, while still guaranteeing the maximal 








Table 3.1 Discordance rates for imputations for real sequencing data.  Data are from 
chromosome 20 of individuals with European ancestry in the 1000 Genomes Project. 
Discordance rates are shown as percentages. We split 381 phased diploid individuals into 
a target sample of 301 target individuals and a reference panel of 160 haplotypes. Shown 
here are results from one imputation with the most diverse reference panel and the mean 
and standard deviation of the discordance rates from 50 imputations with randomly 
selected reference panels. We ranked discordance rates of the most diverse panel together 
with 50 random reference panels from the lowest to the highest value and display the 




All Heterozygotes MAF(0,0.1) MAF[0.1,0.2) MAF[0.2,0.5] 
Most diverse 1.02 3.53 10.31 2.77 1.92 
Random 
 
mean 1.03 3.57 10.45 2.82 1.93 
standard 
deviation 
0.004 0.019 0.076 0.019 0.014 
Rank of the most 
diverse 






Figure 3.1 Illustration of the selection of the most phylogenetically diverse reference 
panel.  Shown is the phylogenetic tree constructed from 20 simulated haplotypes as well 
as the most diverse subset of five taxa (in bold). The selection algorithm first selects the 
most distant pair of taxa and then identifies haplotypes that are most distant conditional 
on the haplotypes already selected. To choose the five taxa, the greedy algorithm first 
selects pair 1 and 14, and then 12, 19, and 5 sequentially. Notice how the haplotypes 





Figure 3.2 Percentages of polymorphic sites in imputed datasets. The white bar represents 
the accuracy of a random panel, the grey bar represents the accuracy of the diverse 
diploid panel, and the black bar represents the accuracy of the most diverse reference 
panel. If the performance of the diverse diploid reference panel is lower than the 
performance of the random reference panel, this difference is indicated by the part of the 
white bar with horizontal stripes. If the accuracy of the diverse diploid panel is higher 
than the accuracy of the most diverse panel, this difference is indicated by the part of the 
grey bar with vertical stripes. Data are 50 imputed datasets that are sorted in decreasing 









Figure 3.3 Comparison of imputation accuracy.  Boxplots of discordance rates between 
imputed genotypes and simulated genotypes for imputations with randomly chosen 
reference panels, diverse diploid reference panels, and most diverse reference panels. The 
mean discordance rate across the 50 replicates for each comparison group is indicated by 
a diamond, and the median discordance rate across the 50 replicates for each comparison 
group is indicated by a middle line. The horizontal axis labels the comparison on the 
basis of all sites (All), all heterozygote sites (Heterozygotes), and heterozygotes in 





Figure 3.4 Imputation accuracy under different scenarios.  Boxplots of discordance rates 
between imputed genotypes and simulated genotypes for imputations with randomly 
chosen reference panels and most diverse reference panels with varying simulation 
settings: A. Imputation length; B. Reference panel size; C. Number of genotyped markers 
per Mb in the study sample. For each dataset, we examine the mean of 50 random 
reference panels and the most diverse reference panel. The mean discordance rate across 
the 50 replicate simulated datasets for each comparison group is indicated by a diamond, 








Figure 3.5 Imputation accuracy on the 1000 Genomes Project data.  Boxplots of 
discordance rates between imputed genotypes and simulated genotypes for imputations 
with randomly chosen reference panels and most diverse reference panels for eight 100-
kb regions on chromosome 20. We analyzed 762 haplotypes of European ancestry from 
the 1000 Genomes Project. The horizontal axis represents comparison of all sites (All), 
all heterozygote sites (Heterozygotes), and heterozygotes in different MAF groups in the 
simulated sequence data. The mean discordance rate across the eight regions for each 
comparison group is indicated by a diamond, and the median discordance rate across the 










Chapter 4 Selecting the most representative sample in genotype 
imputation for next-generation sequencing 
4.1 Introduction 
Genome-wide association studies (GWAS) have successfully identified many of the 
common genetic variants for complex diseases. With the dramatic cost reduction in next-
generation sequencing technology, investigators have begun to use sequencing studies to 
identify genetic risk variants for complex diseases with a focus on rare variants (Nelson 
et al. 2012; Xia et al. 2012). However, sequencing a large study sample is still very 
expensive. Thus, we need sampling strategies to select an optimal subset such that we can 
identify the maximal number of variable sites in the study sample and achieve the 
maximal imputation accuracy when imputing the sequences for the rest of the study 
sample using the sequenced individuals as references. 
 
Genotype imputation is a statistical approach that predicts genotypes in a less densely 
typed study sample by using information from a more densely genotyped dataset as a 
reference panel. The most commonly used reference panels are sequences from the 
International HapMap Project (The International HapMap Consortium 2005) and the 
1000 Genomes Project (The 1000 Genomes Project Consortium 2010). Investigators have 
used these sequences as reference panels to impute the genotypes for untyped HapMap 
markers in their GWAS. Here, we aim to identify a subset from a study sample to 




rest of the study sample. Sequencing can identify novel variants that are unique to a study 
sample. In addition, compared to imputations with reference sequences from public 
databases such as the International HapMap Project, imputations with reference 
sequences from the study sample itself avoid the possible ancestral background mismatch 
between the reference population and the study population. 
 
We have proposed a sampling strategy for sequencing in Chapter 3, where we propose to 
sequence the subset that has maximal subtree length, a panel we term the most diverse 
reference panel. We show that the most diverse reference panel incorporates more 
polymorphic sties and provides higher imputation accuracy than a randomly selected 
reference panel when imputing the sequences of the rest of study sample for individuals 
from one population or closely related populations. Kang and Marjoram (2012) proposed 
another tree-based method that produced similar results. Both Kang’s method and our 
method assume that the number of mutation events is proportional to the genealogical 
tree length, thus the subtree with the maximal tree length is expected to carry more 
mutant alleles that can be identified by sequencing and consequently to recover more 
variants when used as a reference panel. In addition, it assumes that selected haplotypes 
are spread across the tree, thus could well represent the unselected haplotypes. However, 
this may not be true in some cases, for example, the most diverse subset may oversample 
haplotypes in a cluster on the tree that vastly different while fail to sample any haplotypes 
in a cluster that are similar with small branch lengths (Bordewich et al. 2008). The most 




unselected subset, thus the haplotypes in the unselected subset may not represented well 
by the haplotypes in the selected subset. 
 
Here we propose a subset selection method that considers both the selected subset (R) 
and unselected subset (U). We propose the “most representative” subset, defined by the 
pair (R, U) such that the summation of minimum distances over all unselected haplotypes 
in U to the selected subset R is the smallest among all possible choices of (R, U). 
Because of the combinatorial nature of this problem, it is not computationally feasible to 
compare all instances for a large sample. By our best knowledge, there is no such existing 
approach as the greedy algorithm in Chapter 3 to find such a pair (R,U). Instead, we use a 
local search algorithm, known as the hill-climbing search, to search for the most 
representative panel. The local search algorithm is not systematic, but it has two key 
advantages over an exhaustive search: (1) it uses very little memory – usually constant 
amount; and (2) it can often find reasonable solutions in large state spaces for which 
systematic algorithms are unsuitable (Russell and Norviq 2009). The goal is to find the 
global optimum or a local optimum that is a reasonable approximation of the global 
optimum (Selman and Gomes 2006). To increase the chance of reaching the global 
optimum and minimize the chance of being stuck in local optimum, we randomly start 
multiple times and choose the replicate that has the smallest (R, U) distance as the 
starting point for the hill-climbing search (Figure 4.1). 
 
Using simulated sequences as well as sequences from the 1000 Genomes Project, we 




panel and randomly selected panels so that we can provide guidelines for investigators to 
use when planning sequencing studies with existing genotype data. 
4.2 Materials and methods 
4.2.1 Define the representative panel 
4.2.1.1 Haploid case 
Assume a sample of 2n haplotypes, we want to choose 2k haplotypes as a reference panel 
(k  ≤  n). We represent the selected 2k references in R as I1, I2, …, I2k and represent the 
unselected 2n - 2k haplotypes in U as J1, J2, ...., J2n-2k. For each haplotype j є U, we 
represent the minimum distance to the haplotypes in R as dj = mini  є R {Dji}, where i is the 
haplotype in R that is the closest to j and Dji represents the pair-wise Hamming distance 
between haplotypes j ϵ U and i ϵ R. 
 
The sum of minimum distance for one realization of R and U, represented by (R, U) is, 
 
(   )  ∑       ∑          {   }. 
 
Our goal is to find the realization with minimum distance among all possible realizations 
of (R, U) with size R2k and U2n-2k, the "minimum of minimums", represented by ( ̂  ̂), 
 





4.2.1.2 Diploid case 
Assume a sample of 2n haplotypes, which we randomly pair two haplotypes without 
replacement and form into n diploid individuals. We want to choose k diploid individuals 
out of n phased diploid individuals (k ≤ n). We represent the selected k diploid 
individuals in R as (I1a, I1b), (I2a, I2b), ..., (Ika, Ikb) and represent the unselected n - k 
individuals in U as (J1a, J1b), (J2a, J2b), …, (J(n-k)a, J(n-k)b), where all the individuals are 
phased and they are in arbitrary order. 
 
For each individual j ϵ U, the minimum distance to the selected subset is haplotype i ϵ R, 
defined as 
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      represents the pair-wise Hamming distance between haplotype js and it for s, t ϵ (a, 
b).  
Our goal is to find the realization with minimum distance out of all the possible 
realizations with size Rk and Un-k, represented by ( ̂  ̂),  
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4.2.2 Hill-climbing search algorithm 
Hill-climbing is a greedy local search algorithm that results in a local optimum. To 
increase the chance of reaching the global minimum and to speed up the search, we 
randomly divide the study sample into R and U with a certain size for 100 times and start 
the hill-climbing search with set of (R, U) that has the smallest distances (Figure 4.1).  
4.2.2.1 Implementation: haplotype case 
1. Randomly select 100 subsets (R0, size 2k haplotypes), calculate the distances of 
(R0,U0) for each selection. 
2. Select the set of (R0,U0) that has the smallest distance as starting (R, U). 
3. Randomly replace one haplotype in R with one haplotype from U, recalculate (R, 
U)’, if (R,U)’> (R,U), accept the replacement, otherwise keep the previous subset 
selection. 
4. Repeat step 3 for 100,000 times, record the final selection of (R, U).  
4.2.2.2 Implementation: diploid case 
1. Randomly pair two haplotypes into diploid without replacement. 
2. Randomly select 100 subsets (R0, size k diploids), calculate the distances of 
(R0,U0) for each selection. 
3. Select the set of (R0,U0) that has the smallest distance as the starting (R, U). 
4. Randomly replace one pair of haplotypes in R with one pair of haplotypes from 
U, recalculate (R, U)’. If (R,U)’> (R,U), accept the replacement, otherwise keep 
the previous subset selection. 




4.2.3 Diverse reference panel 
The most diverse panel and diverse diploid are the same as described in Chapter 3, which 
are obtained from the greedy algorithm.   
4.2.4 Imputation accuracy 
We employ minimac (Howie et al. 2012) as one of the best-performing methods, which is 
an extension of MaCH (Li et al. 2010) for phased diploid data. To evaluate the 
imputation accuracy of imputed sites across all individuals in imputed datasets. For each 
site j, the concordance rate for the minor allele is  
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    and  ̂   are the simulated genotype and imputed genotype for individual i at site j, 
represented by the number of minor alleles in that individual (0, 1 and 2) at that site. n is 
the number of diploid individuals in the study sample. 
 
Similarly, the concordance rate for the major allele of site j is 
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We compute the expected heterozygote concordance rate for site j by  
        (    )    (    ) . 







We simulate sequence data using the program ms (Hudson 2002) with parameters and 
datasets created the same as described in Chapter 3. Briefly we first remove singletons 
from the simulated sequences. We create the study samples by randomly choosing ~300 
genotyped SNPs per Mb among markers with MAF ≥ 0.1 and mask the genotypes of all 
other sites. These masked sites are the markers in the study sample for imputation. We 
form diploid individuals by randomly pairing two haplotypes without replacement. We 
consider phased individuals, as we do not focus on phasing.  
 
We simulated 50 datasets. In order to create datasets with imputation target region of 100 
kb, 500 kb, 1 Mb, and 2 Mb, each with a flanking 450 kb region, we simulate 2000 
haplotypes each with 2.9 Mb in total length for each dataset then create each datasets 
with variable lengths (Figure 4.2). We also vary reference sizes from 100, 200, 300, and 
400 and vary genotyped marker density from 100, 300, 500, 700, to 900 SNPs per Mb. 
For each created dataset, we select a representative panel using our method for the 
haploid case and a representative panel for diploid case. For comparison, we also select 
the most diverse, the diverse diploid, and a randomly selected panel. We perform 
imputation with each selected panel and compare their performance. 
4.2.6 The 1000 Genomes Project data 
We apply our method to sequence data from the 1000 Genomes Project. We use the same 
phased data of 381 diploid individuals (762 haplotypes) from five closely related 




selecting ten 1-Mb regions that are approximately evenly distributed across chromosome 
20. We create study samples following similar procedures as the simulated data by 
selecting 300 SNPs per Mb for variants with MAF ≥ 0.1 and mask the genotypes for all 
other SNPs. For each region, we select 160 haplotypes from a total of 762 haplotypes as a 
reference panel. For each dataset, we impute with different reference types and compare 
the SNP discovery rates, allele concordance rates and expected heterozygote concordance 
rates. 
4.3 Results 
4.3.1 Number of iterations for the hill-climbing algorithm  
To evaluate if the local optimum is a reasonable approximation to the global optimum, 
we repeat the search by random start multiple times and select the best one. For selecting 
200 haplotypes out of a total 2000 haplotypes, we randomly start the hill-climbing search 
multiple times and record the distances (R,U) at different number of iterations. We find 
that the (R, U) distance drops quickly during the first 5000 iterations, then it slows down. 
Here in our simulation, we run the update until distance (R, U) reaches zero or up to a 
maximum of 100,000 iterations.  
4.3.2 SNP discovery rate 
For the 50 simulated datasets of each 2000 haplotypes, the number of imputed sites 
ranges from 5,104 to 5,909, with a mean number of 5,437 sites in a 1 Mb region. We 
compute the SNP discovery rate in each selected subset and imputed dataset for the 50 
datasets. We consider a SNP as being discovered if at least one minor allele is present in 





For variants with MAF ≤ 0.005, the representative subset has the highest SNP discovery 
rate in all cases, except that the most diverse subset has the highest discovery rate at 
subset size of 100. For variants with 0.005 < MAF ≤ 0.05, the representative subset has 
the highest SNP discovery rate, followed by the representative diploid, the diverse, the 
diverse diploid, and the random panel across different subset sizes. The randomly 
selected subset has the lowest SNP discovery rate across panel sizes compared to other 
types of subsets. The SNP discovery rates increase with the increase of MAFs and with 
the increase of subset sizes. For variants with 0.005 < MAF ≤ 0.05 and size of 400 
haplotypes, the SNP discovery rate is close to 1 and the differences among different types 
of subsets are smaller (mean rate from 0.962 to 0.989) (Figure 4.3).   
 
We observe the same pattern for SNP discovery rates in imputed datasets. The 
representative subset has the highest SNP discovery rate in all cases except at subset size 
of 100 and variants with MAF ≤ 0.005 (Figure 4.3).  
4.3.3 Imputation accuracy 
4.3.3.1  ̂  from imputation outputs 
As a measure of predicted imputation accuracy generated by MaCH, we compare the 
average  ̂  (defined in Chapter 3) for imputations with different reference types. Figure 
4.4 shows that  ̂  increases with increasing number of reference haplotypes. The 
representative panel performs the best in most cases, whereas the diverse panel works 





4.3.3.2 Allele concordance rate 
We next compare the minor allele concordance rate for imputations with different 
reference types. We observe a higher concordance rate with the increase of MAF or the 
increase of reference panel size. For variants MAF ≥ 0.005, the representative panel 
provides the best minor allele concordance rate, followed by the diploid representative, 
the diverse, the diploid diverse, and the randomly selected panel. The same order applies 
to variants with MAF < 0.005 except imputations with reference panel of 100 haplotypes 
(Figure 4.5).  
4.3.3.3 Expected heterozygote concordance rate 
The expected heterozygote concordance rate has exactly the same pattern as the allele 
concordance rate, and the individual values are also similar (Figure 4.6). We expect it is 
because the allele concordance rate for the major allele of each site is close to 1, thus, the 
expected heterozygote concordance rate for a site Hj ≈ 1 – [Xj(1-1)+1(1-Xj)] = Xj, where 
Xj is the allele concordance rate for the minor allele of the site. 
4.3.4 Different imputation lengths 
To test the performances of different types of reference panels when impute regions of 
different lengths, we perform imputations of different lengths from 100 kb, 500 kb, 1 Mb, 
to 2 Mb by fixing the reference panel size at 200 and the maker density at 300 SNP per 
Mb. The performances of the proposed panels for imputation length of 500 kb or longer 
follows the order of the representative, the representative diploid, the diverse, the diverse 
diploid, and the random panel when comparing SNP discovery rate (Figure 4.7),  ̂  




rate (Figure 4.10). But for imputation with 100 kb, the representative diploid performs 
the worst of all reference types.  
4.3.5 Different marker densities in the study sample 
We test how the maker density of 100, 300, 500, 700, and 900 SNPs per Mb affect 
imputations with each reference type. The SNP discovery rate (Figure 4.11), mean 
 ̂ (Figure 4.12), and minor concordance rate (Figure 4.13) and the expected 
concordance rate (Figure 4.14) slightly increase with increasing number of markers in 
the study sample. For variants with MAF ≥ 0.005, the representative panel provides the 
best performance, followed by the diploid representative, the diverse, the diploid diverse, 
and the randomly selected panel, whereas for rare variants with MAF < 0.005, the diverse 
panel provides a better performance than the representative diploid panel. 
4.3.6 The 1000 Genomes data 
For the 1000 Genomes data, we selected ten 1-Mb regions that are evenly distributed 
across chromosome 20. The number of imputed sites ranges from 2,769 to 4,606, with 
mean equal to 3,873 sites within a 1 Mb region.  
 
The imputation accuracy for imputations from the 1000 Genomes data is lower than that 
from the simulated data. The proposed panels all have better performance than the 
randomly selected reference panels. When comparing the SNP discovery (Figure 4.15),
 
 ̂ (Figure 4.16), the minor allele concordance rate (Figure 4.17) and the expected 
heterozygote concordance rate (Figure 4.18), the diverse panel provides the best 
performance among all reference types. The representative panel and representative 




MAF ≥ 0.005. For rare variants with MAF < 0.005, the diploid diverse performs better 
than the representative and the representative diploid.  
4.4 Discussion 
In this chapter, we propose the representative sample for planning sequencing studies. 
Using simulated sequences, the representative panel performs better than the diverse and 
the randomly selected reference panel in recovering more polymorphic sites from the 
study sample and in providing higher imputation accuracy under most of our simulation 
settings, whereas the diverse reference panel provides better or comparable performance 
to the representative panel when imputing rare variants (MAF ≤ 0.005) or with a small 
reference size (e.g. 100 haplotypes) in simulated data with study individuals from one 
population. In the 1000 Genomes data with study individuals from closely related 
European populations, the most diverse panel works better than other types of reference 
panels. 
 
We expect our method to be applicable to a target genomic region for individuals from 
one population or from closely related populations. For our test regions from 100 kb up to 
2 Mb in the simulated data, the representative panel provides better performance with 
increasing imputation lengths. This might be because the representative algorithm is 
based on the similarity between haplotypes, and longer haplotypes provide more 
information. For the diverse panel, the lengths of imputation regions slightly affect the 
performance of the diverse panel with the best results achieved at the 500 kb region, 
indicating there might be an optimal length where the constructed tree approximates the 





To evaluate the performance of the selected panels in genotype imputation, we find that 
the measures of the minor allele concordance rate and the expected heterozygote 
concordance rate provide similar results for imputation accuracy. We also find that a 
higher SNP discovery rate will often result in a better imputation  ̂  and a higher allele 
concordance rate in imputations.  
 
One limitation for the implementation of the most representative panel is that our hill-
climbing based search can only obtain a local minimum, which might be very different 
from the global minimum. This might count partly why the diverse panel provides a 
better performance than the representative panel when imputing data from the 1000 
Genomes Project. In our simulation, we select multiple (R, U)s but only select the one 
that has the smallest distance as the starting point for the hill-climbing search limited by 
the number of datasets in the simulation. To further optimize the algorithm in practice, 
we can randomly pick multiple starting points, perform the hill-climbing search for each 
starting point, and select the one that provides the smallest final (R, U) distance to 
increase the chance to reach the global minimum. 
 
In summary, we present the most representative sampling strategy for planning sequence 
studies. Using simulated sequence data and real sequence data from the 1000 Genomes 
Project, we show the most representative panel performs better than the most diverse 
panel and randomly selected panels in the majority of simulation settings for individuals 




imputing sequences for individuals from closely related populations in the 1000 Genomes 
data. Further characterizing these two proposed strategies will certainly provide more 







Figure 4.1 Illustration of using multiple random starts in the hill-climbing search.  Shown 
is a one-dimensional state-space of all (R, U) distances. Because the hill-climbing search 
only moves in one direction, here is to decreasing distances, it is important where the 
search starts on the state space. To speed up the hill-climbing search and increase the 
chance to reach the global minimum, we initiate multiple random starts (dot with an 
arrow point to it) and select the one that has the smallest distance as the starting state 








Figure 4.2 Sequence data simulation scheme.  For a total of 2.9 Mb, we impute the 









Figure 4.3 SNP discovery rate in selected subsets and imputed datasets.  A and B: SNP 
discovery rate in reference panels. C and D: SNP discovery rate in imputed datasets. The 
horizontal-axis is the reference panel sizes, The vertical-axis is the discovery rate SNP 
discovery rates in selected subset (A and B) and imputed datasets (C and D) for variants 
with MAF ≤ 0.05. Data are from 50 simulated datasets. Error bars are the standard errors 









Figure 4.4 R-square for imputations with different reference panel sizes. Data are from 50 
simulated datasets. Error bars are the standard errors at each reference panel size for each 








Figure 4.5 Allele concordance rate for imputations of 1 Mb with different reference panel 
types.  Data are from 50 datasets. For each dataset, we performed one imputation with 
each reference panel. The error bars are the standard errors of concordance rates of 
imputed markers at each MAF group.  
 










Figure 4.6 The Expected heterozygote concordance rate. Data are from 50 datasets. For 
each dataset, we performed one imputation with each reference panel. The error bars are 








Figure 4.7 SNP discovery rate for different imputation lengths.  Data from 50 datasets for 











Figure 4.8 R-square for imputations with different target lengths. Data from 50 datasets 









Figure 4.9 Allele concordance rate with different imputation lengths.  Data are from 50 
datasets for each imputation length. Maker density 300 SNPs per Mb. Reference panel 





Figure 4.10 Expected heterozygote concordance rate for different imputation lengths. 
Data are from 50 datasets for each imputation length. Maker density 300 SNPs per Mb. 





Figure 4.11 SNP discovery rate for imputations with different marker densities.  Data are 
from 50 datasets for each maker density. Imputation length is 1Mb. Reference panel size 
of 200 haplotypes. Horizontal axis represents number of SNPs per Mb in the study 
sample. A and B are the discovery rates from selected reference panels. C and D are the 









Figure 4.12 R-square for imputations with different marker densities. Data are from 50 
datasets for each maker density.  Imputation length is 1Mb. Reference panel size of 200 
haplotypes. Horizontal axis represents number of SNPs per Mb in the study sample. A 
and B are the discovery rates from selected reference panels. C and D are the discovery 








Figure 4.13 Allele concordance rate for imputations with different marker density in 
study samples.  Data are from 50 datasets for each maker density. Imputation length is 
1Mb. Reference panel size of 200 haplotypes. Horizontal axis represents number of SNPs 
per Mb in the study sample. A and B are the discovery rates from selected reference 








Figure 4.14 Expected heterozygote concordance rate for different maker density. Data are 
from 50 datasets for each maker density. Imputation length is 1Mb. Reference panel size 
of 200 haplotypes. Horizontal axis represents number of SNPs per Mb in the study 
sample. A and B are the discovery rates from selected reference panels. C and D are the 








Figure 4.15 SNP discovery rate for the 1000 Genomes data.  Data are from ten regions of 
1 Mb from chromosome 20 of EUR ancestry. For a total 381 diploid individuals, select 






Figure 4.16 R-square for imputations of the 1000 Genomes data.  Data are from ten 
regions of 1 Mb from chromosome 20 of EUR ancestry. For a total 381 diploid 











Figure 4.17 Allele concordance rate for the 1000 Genomes data.  Data are from ten 
regions of 1 Mb from chromosome 20 of EUR ancestry. For a total 381 diploid 






Figure 4.18 Expected heterozygote concordance rate for the 1000 Genomes data.  Data 
are from ten regions of 1 Mb from chromosome 20 of EUR ancestry. For a total 381 









Chapter 5 Conclusion 
 
The technological advancements allow investigators to use next-generation sequencing 
data to identify rare genetic variants for complex diseases. However, association tests of 
rare variants require a large sample size to obtain enough counts of the minor alleles to 
gain sufficient statistical power and it is still expensive to sequence a large sample. 
Genotype imputation can augment sequence data while challenges still remain, such as 
imputations of data with population or family structures and imputations of rare variants. 
In this dissertation I develop an approach to apply genotype imputation to family-based 
data and propose two sampling strategies based on existing array data for planning 
sequencing studies with limited budgets.  
 
In Chapter 2, I propose a novel strategy for imputing family-based genotype data in an 
association study for bipolar disorder, with the aim to fine mapping risk loci that 
contribute to a previous observed linkage peak at 8q24. Using about 3,000 SNPs across 
the region in 3,512 individuals from 737 families with European ancestry including the 
families used in previous linkage analysis, I perform a detailed single-maker analysis 
under different genetic models. In addition, I impute the genotypes for all the HapMap 






The reasons for no statistically significant signals found might be multifold. First, bipolar 
disorder is a highly heterogeneous disease, both phenotypically and genetically. Second, 
the limitations of the software on complex family structures may also reduce power in the 
analysis. Third, there may be no risk loci in the studied region.  
 
Future directions for this project involve further characterizing the disease features and 
identifying more variants in the region through sequencing. Because of the high 
heterogeneity of bipolar disorder, selecting a clinically more homogeneous subset of 
patients might increase the power to detect risk loci that contribute to a certain pathway. 
For example, one can select only patients diagnosed with bipolar I disorder, or bipolar 
patients who also have anxiety disorder (Saunders et al. 2009; Saunders et al. 2012). In 
addition, one can identify the estimated number of shared haplotypes at 8q24 in the 
sample and sequence individuals who carry those shared haplotypes. Once new rare 
variants are identified in this region, one can test associations of these novel rare variants 
with bipolar disorder using the entire study sample or other samples through cost-
effective customized arrays. 
 
In Chapter 3 and Chapter 4, I investigate on how to use genotype imputation when 
planning sequencing studies by proposing two sampling strategies based on genotypes 
from existing array data. The goal is to find an optimal subset to sequence, in a sense that 
one can identify the maximal number of variants via sequencing the selected subset, and 
obtaining the maximal imputation accuracy when using the sequenced subset as a 




the property of the selected panel only and aim to make the selected haplotypes to be 
most distinct from each other in order to incorporate the maximal diversity of the sample 
into the selected panel. To achieve this goal, I adapt the phylogenetic diversity and a 
greedy algorithm to select the subset with the maximal subtree length (Pardi and 
Goldman 2005; Steel 2005). The assumption is that the number of mutation events is 
proportional to the evolutional time and the subset with maximal tree length represents 
the longest evolutionary time. In Chapter 4, I consider both the selected haplotypes and 
the unselected haplotypes when identifying the optimal panel. I propose another sampling 
strategy for sequencing studies, termed as the most representative subset. The goal is to 
select a subset such that every unselected haplotype in the study sample has at least one 
similar haplotype in the selected subset that can be used as its template in imputation.  
 
In summary, I present two sampling strategies for planning sequence studies. Both 
strategies provide better performance than randomly selected samples. Both methods 
allow for incorporating other selection criteria.  For example, one can treat individuals 
selected from other criteria as an initial set and apply the algorithm to the initial set as an 
extension. Based on the results from the simulated data as well as the real sequence data 
from the 1000 Genomes Project, I recommend a few guidelines which strategy 
investigators can choose in order to identify maximal polymorphic sites from a study 
sample when planning sequencing studies with existing genotype data: 1) For study 
individuals that are from one population, the representative reference panel is more likely 
to provide a better performance. 2) For study individuals that are from closely related 




The diverse panel might work better than the representative panel when imputing short 
regions (e.g., regions of a few hundred kbs), whereas the representative panel might work 
better when imputing longer regions, e.g., a few Mbs or longer. 4) The differences 
between reference panels become smaller when more individuals are sequenced.  
 
Future work for the most diverse reference panel involves better characterizing the data 
on which the algorithm can work best. For example, Bordewich et al. (2008) found that 
selecting the most diverse subset may not always be the best choice in certain tree 
topologies and proposed an alternative strategy. However, they did not provide a 
systemic measure to categorize the tree topologies. One can better use the algorithm if 
there is a summary statistics that provides such information. Future work for the most 
representative panel involves algorithm optimization. The hill-climbing based approach is 
easy to implement and takes limited memory. But it is often not efficient in finding a 
solution and the solution may not be globally optimal. I intend to further optimize the 
algorithm by borrowing ideas from tag SNPs selection as its idea is similar as the most 
representative panel. 
 
Future directions for both panels include 1) further characterizing the two sampling 
strategies in order to determine when they work the best. My goal is to provide guidelines 
for investigators to select a subset to sequence when they plan sequencing studies. Based 
on simulation results, I have provided several suggestions on which sampling strategy to 
use with a specific study sample. In general, the most diverse algorithm aims to maximize 




imputation accuracy. I intend to characterize the study samples from population genetics 
perspective to see if there exists some summary statistics of a study sample that can be 
used to select the best panel for the specific study sample. 2) Quantifying the gain by 
using the proposed panels than a randomly selected panel, either economically and 
statistically. 3) Combining existing sequence data such as the data from the 1000 
Genomes Project when selecting the optimal reference panel. For example, one can 
identify a subset of the study sample that shares common fragments with sequences from 
the 1000 Genomes Project and get the sequences the selected subset by imputation using 
data from the 1000 Genomes Project as references, while sequencing the rest of the study 
sample that are more different from the sequences from the 1000 Genomes Project. 4) 
Incorporating phenotype information. Ignoring phenotype information in selecting a 
subset to sequence may bias the downstream disease association tests. One can avoid the 
problem by considering sequencing as a SNP discovery step and get genotypes for the 
entire study sample or other samples through more cost-effective customized arrays for 
association tests. Answering these questions and better characterizing the two strategies 
will certainly provide investigators more information in choosing the optimal strategy to 
use when planning sequencing studies in the future. 
 
In summary, in this dissertation, I have addressed challenges and have provided strategies 
in applying genotype imputation to data with family structures and to augment sequence 
data in next-generation sequencing studies. These strategies provide practical solutions to 
the problems arising from identifying risk variants, especially rare risk variants for 




bipolar disorder, but all the proposed methods can be applied to other common complex 
disorders. Currently thoughts of GWAS have been performed with millions of individuals 
involved. I expect that investigators have started to sequence them and will eventually get 
the sequences for all these individuals with phenotypes of interest either by direct 
sequencing or high quality imputation. My dissertation work thus has the potential to 
provide investigators a cost-effective way in get the high quality sequences of a large 
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